| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
09-11-2013, 11:21 AM
|
#1 | ||
|
|||
|
Member
|
The last two days have brought very exciting news on the PD drug development front. Two different biotech programs, supported by significant MJFF grants over the last several years, inked impressive financing deals. These deals mean both of these programs will progress into next phases of clinical testing with deeper pocketed partners. Prime examples of how our efforts to "de-risk" specific programs are bringing results!
Tuesday, Amicus Therapeutics: http://www.marketwatch.com/story/ami...ase-2013-09-10 Today, Civitas: http://www.xconomy.com/boston/2013/0...ons-drug-push/ Yippee! Debi Last edited by Debi Brooks; 09-11-2013 at 12:17 PM. Reason: typo |
||
|
 Reply With Quote
|
| "Thanks for this!" says: | crimsoncrew (09-12-2013), GerryW (09-11-2013), indigogo (09-11-2013), Jim091866 (09-11-2013), lab rat (09-12-2013), Nan Cyclist (09-11-2013), shcg (09-11-2013), soccertese (09-11-2013), Stand Tall (09-11-2013), Tupelo3 (09-11-2013) |
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Back after a set back, a lesson learned about risk factors. | Peripheral Neuropathy | |||
| 3 blown veins 2 days of back to back mris 487 pictures of my brain.... | The Stumble Inn | |||
| neck, upper back and mid back | New Member Introductions | |||
back to back PD deals!
Linear Mode
